Hydrocortone (Hydrocortisone)

Hydrocortone is used under physician guidance for several endocrine and inflammatory conditions.

• Replacement therapy in adrenal insufficiency, including primary or secondary adrenal failure.
• Management of acute or chronic inflammatory disorders such as rheumatoid arthritis or systemic lupus erythematosus.
• Treatment of severe allergic reactions, including asthma exacerbations and skin hypersensitivity.
• Adjunctive therapy for certain autoimmune diseases where immune suppression is required.

• Hydrocortone exerts its effects by binding to intracellular glucocorticoid receptors, forming a receptor‑ligand complex that translocates to the nucleus. This complex interacts with glucocorticoid response elements on DNA, modulating transcription of genes that encode anti‑inflammatory proteins such as annexin‑1 and suppressing pro‑inflammatory cytokines like interleukin‑1, interleukin‑6, and tumor necrosis factor‑α. The net result is reduced leukocyte migration, decreased capillary permeability, and overall immunosuppression.

Like other systemic glucocorticoids, Hydrocortone may cause a range of adverse reactions that vary in frequency and severity.

Common

• Increased appetite and weight gain.
• Fluid retention leading to mild edema.
• Elevated blood glucose levels, especially in patients with diabetes.
• Mood changes such as irritability or mild insomnia.

Serious

• Severe infections due to immunosuppression.
• Osteoporosis or increased risk of fractures.
• Gastrointestinal bleeding or peptic ulcer disease.
• Adrenal suppression causing crisis on abrupt discontinuation.

Healthcare providers should evaluate several factors before initiating Hydrocortone therapy to minimize risks.

• Assess for active infections; glucocorticoids can worsen bacterial, viral, or fungal illnesses.
• Screen for diabetes mellitus or uncontrolled hyperglycemia, as treatment may raise glucose levels.
• Evaluate bone health, particularly in patients with a history of osteoporosis or fractures.
• Monitor blood pressure and electrolyte balance, especially potassium, due to potential sodium retention.
• Use the lowest effective dose for the shortest duration necessary to achieve therapeutic goals.
• Consider tapering the dose gradually when discontinuing to avoid adrenal insufficiency.

Hydrocortone can interact with other medicines, altering its effectiveness or increasing the risk of adverse effects.

Avoid

• Concurrent use with strong CYP3A4 inducers (e.g., rifampin, phenytoin) that may reduce hydrocortisone plasma concentrations.
• Live vaccines, because immunosuppression can diminish vaccine efficacy and increase infection risk.

Use with caution

• Non‑steroidal anti‑inflammatory drugs (NSAIDs) which may raise the chance of gastrointestinal ulceration or bleeding.
• Anticoagulants such as warfarin, as glucocorticoids can affect coagulation parameters.
• Diabetic medications, since hydrocortisone may elevate blood glucose and require dose adjustments.
• Antihypertensive agents, because fluid retention can counteract blood pressure control.